The forecast for pancreas malignant neoplasms mortality in the UK indicates a gradual increase in units, with deaths per hundred thousand persons rising from 15.3 in 2024 to 15.6 in 2028. This reflects moderate year-on-year growth, stabilizing at approximately 0.6% annually from 2026 to 2028. In 2023, this figure stood at 15.2.
Future trends to watch for include advancements in early detection and treatment methods, which may impact mortality rates. Additionally, lifestyle changes and increased awareness of pancreatic cancer risk factors could also alter the trajectory of these forecasts.
